Search

everythinglearnresearchcommunity

for

Search:↓

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Melatonin affects specific gene patterns and biological processes in goat hair growth.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

Type I interferons play a key role in the development of various skin diseases.

Targeting CD169+ skin macrophages may help treat psoriasis.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

The α-MSH-MC1R-cAMP pathway does not protect skin cells from UVA damage.

Adding insulin-like growth factor 1 and bone marrow-derived stem cells to a collagen-chitosan scaffold helps wounds heal faster and regrows hair follicles.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Vitiligo and alopecia areata may have similar causes despite their differences.

RXRα is crucial for proper immune response and links diet to immune function.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Stem cell vesicles reduced eczema symptoms in mice safely.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

MAD2B slows down the growth of skin cells that are important for hair development by interacting with TCF4.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.